Megan Streur1, Sarah J Ratcliffe, Jocasta Ball, Simon Stewart, Barbara Riegel. 1. Megan Streur, RN, MN Doctoral Student, School of Nursing, University of Pennsylvania, Philadelphia. Sarah J. Ratcliffe, PhD Associate Professor, Division of Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia. Jocasta Ball, PhD Postdoctoral Research Fellow, Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia. Simon Stewart, PhD, RN Professor, Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia. Barbara Riegel, PhD, RN Professor, School of Nursing, University of Pennsylvania, Philadelphia.
Abstract
BACKGROUND: Symptom clusters have not previously been explored among individuals with atrial fibrillation of any type. OBJECTIVE: The purpose of this study is to determine the number of symptom clusters present among adults with chronic atrial fibrillation and to explore sociodemographic and clinical factors potentially associated with cluster membership. METHODS: This was a cross-sectional secondary data analysis of 335 Australian community-dwelling adults with chronic (recurrent paroxysmal, persistent, or permanent) atrial fibrillation. We used self-reported symptoms and agglomerative hierarchical cluster analysis to determine the number and content of symptom clusters present. RESULTS: There were slightly more male (52%) than female participants, with a mean (SD) age of 72 (11.25) years. Three symptom clusters were evident, including a vagal cluster (nausea and diaphoresis), a tired cluster (fatigue/lethargy, weakness, syncope/dizziness, and dyspnea/breathlessness), and a heart cluster (chest pain/discomfort and palpitations/fluttering). We compared patient characteristics among those with all the symptoms in the cluster, those with some of the symptoms in the cluster, and those with none of the symptoms in the cluster. The only statistically significant differences were in age, gender, and the use of antiarrhythmic medications for the heart cluster. Women were more likely to have the heart symptom cluster than men were. Individuals with all of the symptoms in the heart cluster were younger (69.6 vs 73.7 years; P = .029) than those with none of the symptoms in the heart cluster and were more likely to be on antiarrhythmic medications. CONCLUSION: Three unique atrial fibrillation symptom clusters were identified in this study population.
RCT Entities:
BACKGROUND: Symptom clusters have not previously been explored among individuals with atrial fibrillation of any type. OBJECTIVE: The purpose of this study is to determine the number of symptom clusters present among adults with chronic atrial fibrillation and to explore sociodemographic and clinical factors potentially associated with cluster membership. METHODS: This was a cross-sectional secondary data analysis of 335 Australian community-dwelling adults with chronic (recurrent paroxysmal, persistent, or permanent) atrial fibrillation. We used self-reported symptoms and agglomerative hierarchical cluster analysis to determine the number and content of symptom clusters present. RESULTS: There were slightly more male (52%) than female participants, with a mean (SD) age of 72 (11.25) years. Three symptom clusters were evident, including a vagal cluster (nausea and diaphoresis), a tired cluster (fatigue/lethargy, weakness, syncope/dizziness, and dyspnea/breathlessness), and a heart cluster (chest pain/discomfort and palpitations/fluttering). We compared patient characteristics among those with all the symptoms in the cluster, those with some of the symptoms in the cluster, and those with none of the symptoms in the cluster. The only statistically significant differences were in age, gender, and the use of antiarrhythmic medications for the heart cluster. Women were more likely to have the heart symptom cluster than men were. Individuals with all of the symptoms in the heart cluster were younger (69.6 vs 73.7 years; P = .029) than those with none of the symptoms in the heart cluster and were more likely to be on antiarrhythmic medications. CONCLUSION: Three unique atrial fibrillation symptom clusters were identified in this study population.
Authors: Melinda J Carrington; Jocasta Ball; John D Horowitz; Thomas H Marwick; Gnanadevan Mahadevan; Chiew Wong; Walter P Abhayaratna; Brian Haluska; David R Thompson; Paul A Scuffham; Simon Stewart Journal: Int J Cardiol Date: 2011-11-12 Impact factor: 4.164
Authors: Anil K Gehi; Samuel Sears; Neeta Goli; T Jennifer Walker; Eugene Chung; Jennifer Schwartz; Kathryn A Wood; Kimberly Guise; J Paul Mounsey Journal: J Cardiovasc Electrophysiol Date: 2012-03-19
Authors: Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy Journal: Circulation Date: 2014-03-28 Impact factor: 29.690
Authors: Laura P Kimble; Sandra B Dunbar; William S Weintraub; Deborah B McGuire; Sharon F Manzo; Ora L Strickland Journal: J Adv Nurs Date: 2011-02-24 Impact factor: 3.187
Authors: Karin S Coyne; Clark Paramore; Susan Grandy; Marco Mercader; Matthew Reynolds; Peter Zimetbaum Journal: Value Health Date: 2006 Sep-Oct Impact factor: 5.725
Authors: Rajeev K Pathak; Melissa E Middeldorp; Megan Meredith; Abhinav B Mehta; Rajiv Mahajan; Christopher X Wong; Darragh Twomey; Adrian D Elliott; Jonathan M Kalman; Walter P Abhayaratna; Dennis H Lau; Prashanthan Sanders Journal: J Am Coll Cardiol Date: 2015-03-16 Impact factor: 24.094
Authors: Megan M Streur; Sarah J Ratcliffe; David J Callans; M Benjamin Shoemaker; Barbara J Riegel Journal: Pacing Clin Electrophysiol Date: 2018-05-15 Impact factor: 1.976
Authors: Catherine J Ryan; Karen M Vuckovic; Lorna Finnegan; Chang G Park; Lani Zimmerman; Bunny Pozehl; Paula Schulz; Susan Barnason; Holli A DeVon Journal: West J Nurs Res Date: 2019-01-22 Impact factor: 1.967
Authors: Megan Streur; Sarah J Ratcliffe; David Callans; M Benjamin Shoemaker; Barbara Riegel Journal: Eur J Cardiovasc Nurs Date: 2018-05-22 Impact factor: 3.908
Authors: Amitava Banerjee; Suliang Chen; Ghazaleh Fatemifar; Mohamad Zeina; R Thomas Lumbers; Johanna Mielke; Simrat Gill; Dipak Kotecha; Daniel F Freitag; Spiros Denaxas; Harry Hemingway Journal: BMC Med Date: 2021-04-06 Impact factor: 11.150